Asia
Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug
Beijing SL Pharmaceutical (SHE:002038) obtained China's regulatory approval for its generic Omega-3 fatty acid ethyl esters 90 soft capsules, branded as Xinfer.The drug is indicated for reducing triglyceride levels in adult patients with severe hypertriglyceridemia, according to a Thursday filing with the Shenzhen bourse.Shares of the pharmaceutical company closed 2% higher Thursday.
SHE:002038
